1 | **Comment**- IMP inhalation solution identical to ventavis inhalation solution, but IMP is in a different volume presentation. Please see covering letter. | 1件: Iloprost Iloprost | 1件: D02721
D02721
| 1件: PTGIR PTGIR 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 1件: 86 86 |
2 | 0.5 mg budesonide effervescent tablet for orodispersible use (Synonym: BUDESONIDE INHALATION) | 1件: Budesonide Budesonide (Synonym: Budesonide Inhalation) | 1件: D00246
D00246
(Name: BUDESONIDE INHALATION) | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 |
3 | 1 mg budesonide effervescent tablet for orodispersible use (Synonym: BUDESONIDE INHALATION) | 1件: Budesonide Budesonide (Synonym: Budesonide Inhalation) | 1件: D00246
D00246
(Name: BUDESONIDE INHALATION) | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 |
4 | 120 mg sodium nitrite inhalation solution | 1件: Nitrite Nitrite | - | - | - | 1件: 86 86 |
5 | 15 mg sodium nitrite inhalation solution | 1件: Nitrite Nitrite | - | - | - | 1件: 86 86 |
6 | 1mg budesonide effervescent tablet for orodispersible use (Synonym: BUDESONIDE INHALATION) | 1件: Budesonide Budesonide (Synonym: Budesonide Inhalation) | 1件: D00246
D00246
(Name: BUDESONIDE INHALATION) | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 |
7 | 25% MTD sodium nitrite inhalation solution | 1件: Nitrite Nitrite | - | - | - | 1件: 86 86 |
8 | 2mg budesonide effervescent tablet for orodispersible use (Synonym: BUDESONIDE INHALATION) | 1件: Budesonide Budesonide (Synonym: Budesonide Inhalation) | 1件: D00246
D00246
(Name: BUDESONIDE INHALATION) | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 |
9 | 4.2% NaCl/Inhalation solution | - | - | - | - | 1件: 299 299 |
10 | 45 mg sodium nitrite inhalation solution | 1件: Nitrite Nitrite | - | - | - | 1件: 86 86 |
11 | 90 mg sodium nitrite inhalation solution | 1件: Nitrite Nitrite | - | - | - | 1件: 86 86 |
12 | AIR001 (sodium nitrite inhalation solution) | 1件: Nitrite Nitrite | - | - | - | 1件: 86 86 |
13 | AIR001 Inhalation Solution | - | - | - | - | 1件: 86 86 |
14 | AIR001 Inhalation Solution (Expansion arm) | - | - | - | - | 1件: 86 86 |
15 | Amiloride Solution for Inhalation | 1件: Amiloride Amiloride | 2件: D00649
D00649
,
D07447
| 3件: SCNN1A SCNN1A, SCNN1B, SCNN1G 💬 | 2件: Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption, Taste transduction 💬 | 1件: 299 299 |
16 | Amyl nitrite inhalation | 2件: Amyl Nitrite Amyl Nitrite, Nitrite | 1件: D00517
D00517
| 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 58 58 |
17 | Apomorphine hydrochloride 1.8mg inhalation powder, pre-dispensed | 1件: Apomorphine Apomorphine | 2件: D02004
D02004
,
D07460
| 2件: DRD1 DRD1, DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
18 | Apomorphine hydrochloride 2.8mg inhalation powder, pre-dispensed | 1件: Apomorphine Apomorphine | 2件: D02004
D02004
,
D07460
| 2件: DRD1 DRD1, DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
19 | Apomorphine hydrochloride 4.0 mg inhalation powder, pre-dispensed | 1件: Apomorphine Apomorphine | 2件: D02004
D02004
,
D07460
| 2件: DRD1 DRD1, DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
20 | Apomorphine hydrochloride 5.8 mg inhalation powder, pre-dispensed | 1件: Apomorphine Apomorphine | 2件: D02004
D02004
,
D07460
| 2件: DRD1 DRD1, DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
21 | AZD5634 for inhalation | - | - | - | - | 1件: 299 299 |
22 | Aztreonam for Inhalation (AI) | 1件: Aztreonam Aztreonam | 2件: D00240
D00240
,
D06558
| - | - | 1件: 299 299 |
23 | Aztreonam for Inhalation Solution | 1件: Aztreonam Aztreonam | 2件: D00240
D00240
,
D06558
| - | - | 1件: 299 299 |
24 | Aztreonam for Inhalation Solution (AZLI) | 1件: Aztreonam Aztreonam | 2件: D00240
D00240
,
D06558
| - | - | 1件: 299 299 |
25 | Aztreonam Lysine for Inhalation | 2件: Aztreonam Aztreonam, Lysine | 3件: D00240
D00240
,
D02304
,
D06558
| - | - | 1件: 299 299 |
26 | Aztreonam Lysine for Inhalation (AZLI) | 2件: Aztreonam Aztreonam, Lysine | 3件: D00240
D00240
,
D02304
,
D06558
| - | - | 1件: 228 228 |
27 | BUDESONIDE (Synonym: BUDESONIDE INHALATION) | 1件: Budesonide Budesonide (Synonym: Budesonide Inhalation) | 1件: D00246
D00246
(Name: BUDESONIDE INHALATION) | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 9件: 66 66, 93, 94, 95, 96, 97, 98, 228, 299 |
28 | Budesonide ( Zentacort Capsules 3mg ) (Synonym: BUDESONIDE INHALATION) | 1件: Budesonide Budesonide (Synonym: Budesonide Inhalation) | 1件: D00246
D00246
(Name: BUDESONIDE INHALATION) | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 96 96 |
29 | Budesonide (6 mg) (Synonym: BUDESONIDE INHALATION) | 1件: Budesonide Budesonide (Synonym: Budesonide Inhalation) | 1件: D00246
D00246
(Name: BUDESONIDE INHALATION) | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 |
30 | Budesonide (9 mg) (Synonym: BUDESONIDE INHALATION) | 1件: Budesonide Budesonide (Synonym: Budesonide Inhalation) | 1件: D00246
D00246
(Name: BUDESONIDE INHALATION) | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 |
31 | Budesonide 0.5 mg compresse orodispersibili (Synonym: BUDESONIDE INHALATION) | 1件: Budesonide Budesonide (Synonym: Budesonide Inhalation) | 1件: D00246
D00246
(Name: BUDESONIDE INHALATION) | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 |
32 | Budesonide 0.5 mg orodispersible tablets (Synonym: BUDESONIDE INHALATION) | 1件: Budesonide Budesonide (Synonym: Budesonide Inhalation) | 1件: D00246
D00246
(Name: BUDESONIDE INHALATION) | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 |
33 | Budesonide 0.5mg orodispersible tablet twice daily (Synonym: BUDESONIDE INHALATION) | 1件: Budesonide Budesonide (Synonym: Budesonide Inhalation) | 1件: D00246
D00246
(Name: BUDESONIDE INHALATION) | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 |
34 | Budesonide 1 mg compresse orodispersibili (Synonym: BUDESONIDE INHALATION) | 1件: Budesonide Budesonide (Synonym: Budesonide Inhalation) | 1件: D00246
D00246
(Name: BUDESONIDE INHALATION) | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 |
35 | Budesonide 1 mg orodispersible tablets (Synonym: BUDESONIDE INHALATION) | 1件: Budesonide Budesonide (Synonym: Budesonide Inhalation) | 1件: D00246
D00246
(Name: BUDESONIDE INHALATION) | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 |
36 | Budesonide 1 mg orodispersible tablets (BUL 1 mg) (Synonym: BUDESONIDE INHALATION) | 1件: Budesonide Budesonide (Synonym: Budesonide Inhalation) | 1件: D00246
D00246
(Name: BUDESONIDE INHALATION) | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 |
37 | Budesonide 1mg orodispersible tablet twice daily (Synonym: BUDESONIDE INHALATION) | 1件: Budesonide Budesonide (Synonym: Budesonide Inhalation) | 1件: D00246
D00246
(Name: BUDESONIDE INHALATION) | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 |
38 | Budesonide 2 mg orodispersible tablets (BUL 2 mg) (Synonym: BUDESONIDE INHALATION) | 1件: Budesonide Budesonide (Synonym: Budesonide Inhalation) | 1件: D00246
D00246
(Name: BUDESONIDE INHALATION) | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 |
39 | Budesonide 6 mg prolonged-release capsule, hard (BUX-PVII prototype) (Synonym: BUDESONIDE INHALATION) | 1件: Budesonide Budesonide (Synonym: Budesonide Inhalation) | 1件: D00246
D00246
(Name: BUDESONIDE INHALATION) | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 |
40 | Budesonide 6 mg prolonged-release capsules, hard (BUX-PVII prototype) (Synonym: BUDESONIDE INHALATION) | 1件: Budesonide Budesonide (Synonym: Budesonide Inhalation) | 1件: D00246
D00246
(Name: BUDESONIDE INHALATION) | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 |
41 | Budesonide 9 mg capsules, hard (BUX-PV) (Synonym: BUDESONIDE INHALATION) | 1件: Budesonide Budesonide (Synonym: Budesonide Inhalation) | 1件: D00246
D00246
(Name: BUDESONIDE INHALATION) | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 |
42 | Budesonide 9 mg prolonged-release capsule, hard (BUX-PVII prototype) (Synonym: BUDESONIDE INHALATION) | 1件: Budesonide Budesonide (Synonym: Budesonide Inhalation) | 1件: D00246
D00246
(Name: BUDESONIDE INHALATION) | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 |
43 | Budesonide 9 mg prolonged-release capsules, hard (BUX-PVII prototype) (Synonym: BUDESONIDE INHALATION) | 1件: Budesonide Budesonide (Synonym: Budesonide Inhalation) | 1件: D00246
D00246
(Name: BUDESONIDE INHALATION) | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 |
44 | Budesonide [0.4mg/ml] viscous suspension (Synonym: BUDESONIDE INHALATION) | 1件: Budesonide Budesonide (Synonym: Budesonide Inhalation) | 1件: D00246
D00246
(Name: BUDESONIDE INHALATION) | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 |
45 | Budesonide MMX (Synonym: BUDESONIDE INHALATION) | 1件: Budesonide Budesonide (Synonym: Budesonide Inhalation) | 1件: D00246
D00246
(Name: BUDESONIDE INHALATION) | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 |
46 | Budesonide MMX 6 mg Tablet (Synonym: BUDESONIDE INHALATION) | 1件: Budesonide Budesonide (Synonym: Budesonide Inhalation) | 1件: D00246
D00246
(Name: BUDESONIDE INHALATION) | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 |
47 | Budesonide MMX® (Synonym: BUDESONIDE INHALATION) | 1件: Budesonide Budesonide (Synonym: Budesonide Inhalation) | 1件: D00246
D00246
(Name: BUDESONIDE INHALATION) | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 |
48 | Budesonide MMX® 6 mg (Synonym: BUDESONIDE INHALATION) | 1件: Budesonide Budesonide (Synonym: Budesonide Inhalation) | 1件: D00246
D00246
(Name: BUDESONIDE INHALATION) | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 |
49 | Budesonide MMX® 9 mg (Synonym: BUDESONIDE INHALATION) | 1件: Budesonide Budesonide (Synonym: Budesonide Inhalation) | 1件: D00246
D00246
(Name: BUDESONIDE INHALATION) | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 |
50 | Budesonide oral suspension (Synonym: BUDESONIDE INHALATION) | 1件: Budesonide Budesonide (Synonym: Budesonide Inhalation) | 1件: D00246
D00246
(Name: BUDESONIDE INHALATION) | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 |
51 | Budesonide oral suspension [0.2 mg/ml] (Synonym: BUDESONIDE INHALATION) | 1件: Budesonide Budesonide (Synonym: Budesonide Inhalation) | 1件: D00246
D00246
(Name: BUDESONIDE INHALATION) | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 |
52 | Budesonide plus Prevacid (Synonym: BUDESONIDE INHALATION) | 1件: Budesonide Budesonide (Synonym: Budesonide Inhalation) | 1件: D00246
D00246
(Name: BUDESONIDE INHALATION) | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 |
53 | Budesonide-formoterol single inhaler (Synonym: BUDESONIDE INHALATION) | 2件: Budesonide Budesonide (Synonym: Budesonide Inhalation), Formoterol (Synonym: Glycopyrronium / Formoterol Fumarate Dihydrate Pressurized Inhalation Aerosol) | 4件: D00246
D00246
(Name: BUDESONIDE INHALATION),
D01373
,
D05277
,
D07990
| 2件: ADRB2 ADRB2, NR3C1 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 299 299 |
54 | Budesonide-MMX (Synonym: BUDESONIDE INHALATION) | 1件: Budesonide Budesonide (Synonym: Budesonide Inhalation) | 1件: D00246
D00246
(Name: BUDESONIDE INHALATION) | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 |
55 | Budesonide-MMX® (Synonym: BUDESONIDE INHALATION) | 1件: Budesonide Budesonide (Synonym: Budesonide Inhalation) | 1件: D00246
D00246
(Name: BUDESONIDE INHALATION) | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 |
56 | Budesonide-MMX® 6 mg (Synonym: BUDESONIDE INHALATION) | 1件: Budesonide Budesonide (Synonym: Budesonide Inhalation) | 1件: D00246
D00246
(Name: BUDESONIDE INHALATION) | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 |
57 | Budesonide-MMX® 9 mg (Synonym: BUDESONIDE INHALATION) | 1件: Budesonide Budesonide (Synonym: Budesonide Inhalation) | 1件: D00246
D00246
(Name: BUDESONIDE INHALATION) | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 |
58 | Budesonide-MMX™ (Synonym: BUDESONIDE INHALATION) | 1件: Budesonide Budesonide (Synonym: Budesonide Inhalation) | 1件: D00246
D00246
(Name: BUDESONIDE INHALATION) | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 |
59 | Budesonide/formoterol (Synonym: BUDESONIDE INHALATION) | 2件: Budesonide Budesonide (Synonym: Budesonide Inhalation), Formoterol (Synonym: Glycopyrronium / Formoterol Fumarate Dihydrate Pressurized Inhalation Aerosol) | 4件: D00246
D00246
(Name: BUDESONIDE INHALATION),
D01373
,
D05277
,
D07990
| 2件: ADRB2 ADRB2, NR3C1 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 228 228 |
60 | Ceftazidime and tobramycin (Synonym: TOBRAMYCIN INHALATION) | 2件: Ceftazidime Ceftazidime, Tobramycin (Synonym: Tobramycin Inhalation Solution USP) | 4件: D00063
D00063
(Name: TOBRAMYCIN INHALATION),
D00921
,
D02542
,
D07654
| - | - | 1件: 299 299 |
61 | Ciprofloxacin (BAYQ3939) dry powder for inhalation | 1件: Ciprofloxacin Ciprofloxacin | 2件: D00186
D00186
,
D02216
| - | - | 1件: 299 299 |
62 | Ciprofloxacin dispersion for inhalation | 1件: Ciprofloxacin Ciprofloxacin | 2件: D00186
D00186
,
D02216
| - | - | 1件: 299 299 |
63 | Ciprofloxacin for Inhalation | 1件: Ciprofloxacin Ciprofloxacin | 2件: D00186
D00186
,
D02216
| - | - | 1件: 299 299 |
64 | COLIMYCINE inhalation | - | - | - | - | 1件: 299 299 |
65 | Combination Oral Budesonide and Rectal Hydrocortisone (Synonym: BUDESONIDE INHALATION) | 2件: Budesonide Budesonide (Synonym: Budesonide Inhalation), Hydrocortisone | 2件: D00088
D00088
,
D00246
(Name: BUDESONIDE INHALATION) | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 |
66 | Compressa effervescente 0,5 mg di budesonide per uso orodispersibile (Synonym: BUDESONIDE INHALATION) | 1件: Budesonide Budesonide (Synonym: Budesonide Inhalation) | 1件: D00246
D00246
(Name: BUDESONIDE INHALATION) | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 |
67 | Compressa effervescente 1 mg di budesonide per uso orodispersibile (Synonym: BUDESONIDE INHALATION) | 1件: Budesonide Budesonide (Synonym: Budesonide Inhalation) | 1件: D00246
D00246
(Name: BUDESONIDE INHALATION) | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 |
68 | Cyclosporine A dry powder inhalation (Drug) | 1件: Cyclosporine Cyclosporine | 1件: D00184
D00184
| 5件: PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 228 228 |
69 | Cyclosporine Inhalation Solution | 1件: Cyclosporine Cyclosporine | 1件: D00184
D00184
| 5件: PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 228 228 |
70 | Cyclosporine Inhalation Solution (CIS) | 1件: Cyclosporine Cyclosporine | 1件: D00184
D00184
| 5件: PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 228 228 |
71 | Denufosol Tetrasodium (INS37217) Inhalation Solution | 1件: Denufosol Denufosol | - | - | - | 1件: 299 299 |
72 | Denufosol tetrasodium Inhalation Solution | 1件: Denufosol Denufosol | - | - | - | 1件: 299 299 |
73 | Dry powder tobramycin (Synonym: TOBRAMYCIN INHALATION) | 1件: Tobramycin Tobramycin (Synonym: Tobramycin Inhalation Solution USP) | 2件: D00063
D00063
(Name: TOBRAMYCIN INHALATION),
D02542
| - | - | 1件: 299 299 |
74 | Formoterol/Budesonide (Synonym: BUDESONIDE INHALATION) | 2件: Budesonide Budesonide (Synonym: Budesonide Inhalation), Formoterol (Synonym: Glycopyrronium / Formoterol Fumarate Dihydrate Pressurized Inhalation Aerosol) | 4件: D00246
D00246
(Name: BUDESONIDE INHALATION),
D01373
,
D05277
,
D07990
| 2件: ADRB2 ADRB2, NR3C1 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 228 228 |
75 | GM-CSF inhalation therapy | - | - | - | - | 1件: 229 229 |
76 | Helium / oxygen mixed gas inhalation therapy | 2件: Helium Helium, Oxygen | 2件: D00003
D00003
,
D04420
| - | - | 1件: 330 330 |
77 | Heparin 25mg inhalation powder, hard capsule | 1件: Heparin Heparin | 1件: D07510
D07510
| 1件: SERPINC1 SERPINC1 💬 | 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 1件: 299 299 |
78 | High Dose Budesonide (Synonym: BUDESONIDE INHALATION) | 1件: Budesonide Budesonide (Synonym: Budesonide Inhalation) | 1件: D00246
D00246
(Name: BUDESONIDE INHALATION) | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 |
79 | High dose budesonide suspension (Synonym: BUDESONIDE INHALATION) | 1件: Budesonide Budesonide (Synonym: Budesonide Inhalation) | 1件: D00246
D00246
(Name: BUDESONIDE INHALATION) | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 |
80 | High dose budesonide tablet (Synonym: BUDESONIDE INHALATION) | 1件: Budesonide Budesonide (Synonym: Budesonide Inhalation) | 1件: D00246
D00246
(Name: BUDESONIDE INHALATION) | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 |
81 | High dose of budesonide (Synonym: BUDESONIDE INHALATION) | 1件: Budesonide Budesonide (Synonym: Budesonide Inhalation) | 1件: D00246
D00246
(Name: BUDESONIDE INHALATION) | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 299 299 |
82 | Hyaluronic Acid Inhalation Solution | 1件: Hyaluronic acid Hyaluronic acid | 1件: D08043
D08043
| - | - | 1件: 231 231 |
83 | Iloprost Inhalation Solution (Ventavis) | 1件: Iloprost Iloprost | 1件: D02721
D02721
| 1件: PTGIR PTGIR 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 2件: 85 85, 86 |
84 | Inhalation | - | - | - | - | 1件: 228 228 |
85 | Inhaled tobramycin (Synonym: TOBRAMYCIN INHALATION) | 1件: Tobramycin Tobramycin (Synonym: Tobramycin Inhalation Solution USP) | 2件: D00063
D00063
(Name: TOBRAMYCIN INHALATION),
D02542
| - | - | 1件: 299 299 |
86 | Inhaled/swallowed budesonide (Synonym: BUDESONIDE INHALATION) | 1件: Budesonide Budesonide (Synonym: Budesonide Inhalation) | 1件: D00246
D00246
(Name: BUDESONIDE INHALATION) | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 |
87 | INOmax 400ppm mol/mol inhalation gas | 1件: Nitric Oxide Nitric Oxide | 1件: D00074
D00074
| - | - | 2件: 85 85, 299 |
88 | IV tobramycin (Synonym: TOBRAMYCIN INHALATION) | 1件: Tobramycin Tobramycin (Synonym: Tobramycin Inhalation Solution USP) | 2件: D00063
D00063
(Name: TOBRAMYCIN INHALATION),
D02542
| - | - | 1件: 299 299 |
89 | Kamada -AAT for Inhalation or inhaled AAT (AAT) | - | - | - | - | 1件: 231 231 |
90 | Kamada-AAT for inhalation | - | - | - | - | 1件: 231 231 |
91 | Kamada-AAT for Inhalation, 160mg | - | - | - | - | 1件: 231 231 |
92 | Kamada-AAT for Inhalation, 80mg | - | - | - | - | 1件: 231 231 |
93 | L606 (Liposomal Treprostinil) Inhalation Solution 51ug | 1件: Treprostinil Treprostinil | 1件: D06213
D06213
| 1件: PTGIR PTGIR 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 1件: 86 86 |
94 | L606 Inhalation System | - | - | - | - | 1件: 86 86 |
95 | Levodopa powder for inhalation | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
96 | Liposomal amikacin for inhalation | 1件: Amikacin Amikacin | 2件: D00865
D00865
,
D02543
| - | - | 1件: 299 299 |
97 | Liposomal amikacin for inhalation (Arikayce™) using the PARI Investigational eFlow® Nebulizer. | 1件: Amikacin Amikacin | 2件: D00865
D00865
,
D02543
| - | - | 1件: 299 299 |
98 | Low Dose Budesonide (Synonym: BUDESONIDE INHALATION) | 1件: Budesonide Budesonide (Synonym: Budesonide Inhalation) | 1件: D00246
D00246
(Name: BUDESONIDE INHALATION) | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 |
99 | Low dose budesonide tablet (Synonym: BUDESONIDE INHALATION) | 1件: Budesonide Budesonide (Synonym: Budesonide Inhalation) | 1件: D00246
D00246
(Name: BUDESONIDE INHALATION) | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 |
100 | Mannitol inhalation powder | 1件: Mannitol Mannitol | 1件: D00062
D00062
| - | - | 1件: 299 299 |
101 | Methylprednisolone or budesonide (Synonym: BUDESONIDE INHALATION) | 2件: Budesonide Budesonide (Synonym: Budesonide Inhalation), Methylprednisolone | 7件: D00246
D00246
(Name: BUDESONIDE INHALATION),
D00407
,
D00751
,
D00979
,
D05000
,
D05001
,
D05002
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 96 96 |
102 | MP-376 (Levofloxacin Solution for Inhalation) | 1件: Levofloxacin Levofloxacin | 2件: D00588
D00588
,
D08120
| - | - | 1件: 299 299 |
103 | Nebcin (tobramycin) (Synonym: TOBRAMYCIN INHALATION) | 1件: Tobramycin Tobramycin (Synonym: Tobramycin Inhalation Solution USP) | 2件: D00063
D00063
(Name: TOBRAMYCIN INHALATION),
D02542
| - | - | 1件: 299 299 |
104 | Nebulization tobramycin (Synonym: TOBRAMYCIN INHALATION) | 1件: Tobramycin Tobramycin (Synonym: Tobramycin Inhalation Solution USP) | 2件: D00063
D00063
(Name: TOBRAMYCIN INHALATION),
D02542
| - | - | 1件: 299 299 |
105 | Nitric Oxide for inhalation | 1件: Nitric Oxide Nitric Oxide | 1件: D00074
D00074
| - | - | 2件: 86 86, 299 |
106 | OligoG CF-5/20, 17,5 mg, Hartkapsel mit Pulver zur Inhalation | - | - | - | - | 1件: 299 299 |
107 | OligoG CF/20, 27,5 mg, Hartkapsel mit Pulver zur Inhalation | - | - | - | - | 1件: 299 299 |
108 | OligoG CF/20, 37,5 mg, Hartkapsel mit Pulver zur Inhalation | - | - | - | - | 1件: 299 299 |
109 | OligoG Dry powder for inhalation | - | - | - | - | 1件: 299 299 |
110 | Oral Budesonide (Synonym: BUDESONIDE INHALATION) | 1件: Budesonide Budesonide (Synonym: Budesonide Inhalation) | 1件: D00246
D00246
(Name: BUDESONIDE INHALATION) | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 |
111 | Oral Budesonide Suspension (MB-9) (Synonym: BUDESONIDE INHALATION) | 1件: Budesonide Budesonide (Synonym: Budesonide Inhalation) | 1件: D00246
D00246
(Name: BUDESONIDE INHALATION) | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 |
112 | Oral Budesonide Suspension (OBS) (Synonym: BUDESONIDE INHALATION) | 1件: Budesonide Budesonide (Synonym: Budesonide Inhalation) | 1件: D00246
D00246
(Name: BUDESONIDE INHALATION) | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 |
113 | Oral Viscous Budesonide (Synonym: BUDESONIDE INHALATION) | 1件: Budesonide Budesonide (Synonym: Budesonide Inhalation) | 1件: D00246
D00246
(Name: BUDESONIDE INHALATION) | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 |
114 | Oral Viscous Budesonide (OVB) (Synonym: BUDESONIDE INHALATION) | 1件: Budesonide Budesonide (Synonym: Budesonide Inhalation) | 1件: D00246
D00246
(Name: BUDESONIDE INHALATION) | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 |
115 | Other: Tobramycin time of administration (Synonym: TOBRAMYCIN INHALATION) | 1件: Tobramycin Tobramycin (Synonym: Tobramycin Inhalation Solution USP) | 2件: D00063
D00063
(Name: TOBRAMYCIN INHALATION),
D02542
| - | - | 1件: 299 299 |
116 | Pirfenidone Solution for Inhalation | 1件: Pirfenidone Pirfenidone | 1件: D01583
D01583
| 6件: CCL2 CCL2, IL10, IL1A, IL1B, IL6, TNF 💬 | 84件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 85 85 |
117 | Radiolabelled OligoG CF-5/20 Dry Powder for Inhalation (DPI) | - | - | - | - | 1件: 299 299 |
118 | RT234 - vardenafil inhalation powder | 1件: Vardenafil Vardenafil | 3件: D02731
D02731
,
D03260
,
D08668
| 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
119 | Saline 0.9% inhalation solution | - | - | - | - | 1件: 299 299 |
120 | Sodium Nitrite Inhalation Solution | 1件: Nitrite Nitrite | - | - | - | 1件: 86 86 |
121 | Spiriva Respimat 2.5 microgram, solution for inhalation | 1件: Tiotropium Tiotropium | - | - | - | 1件: 299 299 |
122 | Tiotropium Respimat 1.25 microgram solution for inhalation | 1件: Tiotropium Tiotropium | - | - | - | 1件: 299 299 |
123 | Tiotropium Respimat 1.25 microgram, solution for inhalation | 1件: Tiotropium Tiotropium | - | - | - | 1件: 299 299 |
124 | Tiotropium Respimat 1.25 micrograms solution for inhalation | 1件: Tiotropium Tiotropium | - | - | - | 1件: 299 299 |
125 | TIP (Tobramycin inhalation powder) | 1件: Tobramycin Tobramycin (Synonym: Tobramycin Inhalation Solution USP) | 2件: D00063
D00063
(Name: TOBRAMYCIN INHALATION),
D02542
| - | - | 1件: 299 299 |
126 | TIS (Tobramycin Inhalation Solution) | 1件: Tobramycin Tobramycin (Synonym: Tobramycin Inhalation Solution USP) | 2件: D00063
D00063
(Name: TOBRAMYCIN INHALATION),
D02542
| - | - | 1件: 299 299 |
127 | TOBI (tobramycin) (Synonym: TOBRAMYCIN INHALATION) | 1件: Tobramycin Tobramycin (Synonym: Tobramycin Inhalation Solution USP) | 2件: D00063
D00063
(Name: TOBRAMYCIN INHALATION),
D02542
| - | - | 1件: 299 299 |
128 | TOBI 300 mg/5 ml, solution pour inhalation par nébuliseur | 1件: Tobramycin Tobramycin (Synonym: Tobramycin Inhalation Solution USP) | 2件: D00063
D00063
(Name: TOBRAMYCIN INHALATION),
D02542
| - | - | 1件: 299 299 |
129 | TOBI Podhaler 28 mg Hartkapseln mit Pulver zur Inhalation | 1件: Tobramycin Tobramycin (Synonym: Tobramycin Inhalation Solution USP) | 2件: D00063
D00063
(Name: TOBRAMYCIN INHALATION),
D02542
| - | - | 1件: 299 299 |
130 | TOBRAMYCIN (Synonym: TOBRAMYCIN INHALATION) | 1件: Tobramycin Tobramycin (Synonym: Tobramycin Inhalation Solution USP) | 2件: D00063
D00063
(Name: TOBRAMYCIN INHALATION),
D02542
| - | - | 1件: 299 299 |
131 | Tobramycin (Gernebcin®) (Synonym: TOBRAMYCIN INHALATION) | 1件: Tobramycin Tobramycin (Synonym: Tobramycin Inhalation Solution USP) | 2件: D00063
D00063
(Name: TOBRAMYCIN INHALATION),
D02542
| - | - | 1件: 299 299 |
132 | Tobramycin / Bramitob (Synonym: TOBRAMYCIN INHALATION) | 1件: Tobramycin Tobramycin (Synonym: Tobramycin Inhalation Solution USP) | 2件: D00063
D00063
(Name: TOBRAMYCIN INHALATION),
D02542
| - | - | 1件: 299 299 |
133 | Tobramycin / TOBI (Synonym: TOBRAMYCIN INHALATION) | 1件: Tobramycin Tobramycin (Synonym: Tobramycin Inhalation Solution USP) | 2件: D00063
D00063
(Name: TOBRAMYCIN INHALATION),
D02542
| - | - | 1件: 299 299 |
134 | Tobramycin 100 PARI (Synonym: TOBRAMYCIN INHALATION) | 1件: Tobramycin Tobramycin (Synonym: Tobramycin Inhalation Solution USP) | 2件: D00063
D00063
(Name: TOBRAMYCIN INHALATION),
D02542
| - | - | 1件: 299 299 |
135 | Tobramycin dry powder (Synonym: TOBRAMYCIN INHALATION) | 1件: Tobramycin Tobramycin (Synonym: Tobramycin Inhalation Solution USP) | 2件: D00063
D00063
(Name: TOBRAMYCIN INHALATION),
D02542
| - | - | 1件: 299 299 |
136 | Tobramycin for Inhalation | 1件: Tobramycin Tobramycin (Synonym: Tobramycin Inhalation Solution USP) | 2件: D00063
D00063
(Name: TOBRAMYCIN INHALATION),
D02542
| - | - | 1件: 299 299 |
137 | Tobramycin Inhalation Powder | 1件: Tobramycin Tobramycin (Synonym: Tobramycin Inhalation Solution USP) | 2件: D00063
D00063
(Name: TOBRAMYCIN INHALATION),
D02542
| - | - | 1件: 299 299 |
138 | Tobramycin Inhalation Powder (TIP) | 1件: Tobramycin Tobramycin (Synonym: Tobramycin Inhalation Solution USP) | 2件: D00063
D00063
(Name: TOBRAMYCIN INHALATION),
D02542
| - | - | 1件: 299 299 |
139 | Tobramycin Inhalation Powder TIP delivered by the T-326 Inhaler | 1件: Tobramycin Tobramycin (Synonym: Tobramycin Inhalation Solution USP) | 2件: D00063
D00063
(Name: TOBRAMYCIN INHALATION),
D02542
| - | - | 1件: 299 299 |
140 | Tobramycin inhalation solution | 1件: Tobramycin Tobramycin (Synonym: Tobramycin Inhalation Solution USP) | 2件: D00063
D00063
(Name: TOBRAMYCIN INHALATION),
D02542
| - | - | 1件: 299 299 |
141 | Tobramycin Inhalation Solution (TIS) | 1件: Tobramycin Tobramycin (Synonym: Tobramycin Inhalation Solution USP) | 2件: D00063
D00063
(Name: TOBRAMYCIN INHALATION),
D02542
| - | - | 1件: 299 299 |
142 | Tobramycin inhalation solution using a PARI LC® Plus nebulizer. | 1件: Tobramycin Tobramycin (Synonym: Tobramycin Inhalation Solution USP) | 2件: D00063
D00063
(Name: TOBRAMYCIN INHALATION),
D02542
| - | - | 1件: 299 299 |
143 | Tobramycin injection 40mg/1ml (Synonym: TOBRAMYCIN INHALATION) | 1件: Tobramycin Tobramycin (Synonym: Tobramycin Inhalation Solution USP) | 2件: D00063
D00063
(Name: TOBRAMYCIN INHALATION),
D02542
| - | - | 1件: 299 299 |
144 | Tobramycin nebulized nasally (Synonym: TOBRAMYCIN INHALATION) | 1件: Tobramycin Tobramycin (Synonym: Tobramycin Inhalation Solution USP) | 2件: D00063
D00063
(Name: TOBRAMYCIN INHALATION),
D02542
| - | - | 1件: 299 299 |
145 | Tobramycin Powder (Synonym: TOBRAMYCIN INHALATION) | 1件: Tobramycin Tobramycin (Synonym: Tobramycin Inhalation Solution USP) | 2件: D00063
D00063
(Name: TOBRAMYCIN INHALATION),
D02542
| - | - | 1件: 299 299 |
146 | Tobramycin Solution for Inhalation | 1件: Tobramycin Tobramycin (Synonym: Tobramycin Inhalation Solution USP) | 2件: D00063
D00063
(Name: TOBRAMYCIN INHALATION),
D02542
| - | - | 1件: 299 299 |
147 | Tobramycin solution for inhalation (TOBI) | 1件: Tobramycin Tobramycin (Synonym: Tobramycin Inhalation Solution USP) | 2件: D00063
D00063
(Name: TOBRAMYCIN INHALATION),
D02542
| - | - | 1件: 299 299 |
148 | Tobramycin solution for inhalation 300 mg | 1件: Tobramycin Tobramycin (Synonym: Tobramycin Inhalation Solution USP) | 2件: D00063
D00063
(Name: TOBRAMYCIN INHALATION),
D02542
| - | - | 1件: 299 299 |
149 | Tobramycin Steri-Neb 300 mg/5 ml, inhalation solution | 1件: Tobramycin Tobramycin (Synonym: Tobramycin Inhalation Solution USP) | 2件: D00063
D00063
(Name: TOBRAMYCIN INHALATION),
D02542
| - | - | 1件: 299 299 |
150 | TOBRAMYCIN SULFATE (Synonym: TOBRAMYCIN INHALATION) | 2件: Sulfate ion Sulfate ion, Tobramycin (Synonym: Tobramycin Inhalation Solution USP) | 2件: D00063
D00063
(Name: TOBRAMYCIN INHALATION),
D02542
| - | - | 1件: 299 299 |
151 | Treprostinil Inhalation Powder | 1件: Treprostinil Treprostinil | 1件: D06213
D06213
| 1件: PTGIR PTGIR 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 1件: 86 86 |
152 | Treprostinil inhalations | 1件: Treprostinil Treprostinil | 1件: D06213
D06213
| 1件: PTGIR PTGIR 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 1件: 86 86 |
153 | Treprostinil sodium for inhalation | 1件: Treprostinil Treprostinil | 1件: D06213
D06213
| 1件: PTGIR PTGIR 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 1件: 85 85 |
154 | Treprostinil Sodium Solution for Inhalation | 1件: Treprostinil Treprostinil | 1件: D06213
D06213
| 1件: PTGIR PTGIR 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 1件: 86 86 |
155 | Tyvaso Inhalation Solution | 1件: Treprostinil Treprostinil | 1件: D06213
D06213
| 1件: PTGIR PTGIR 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 1件: 86 86 |
156 | Vancomycin hydrochloride inhalation powder | 1件: Vancomycin Vancomycin | 2件: D00212
D00212
,
D00926
| - | - | 1件: 299 299 |
157 | Vancomycin inhalation powder | 1件: Vancomycin Vancomycin | 2件: D00212
D00212
,
D00926
| - | - | 1件: 299 299 |
158 | Vantobra (tobramycin) (Synonym: TOBRAMYCIN INHALATION) | 1件: Tobramycin Tobramycin (Synonym: Tobramycin Inhalation Solution USP) | 2件: D00063
D00063
(Name: TOBRAMYCIN INHALATION),
D02542
| - | - | 1件: 299 299 |
159 | Viscous/swallowed budesonide (Synonym: BUDESONIDE INHALATION) | 1件: Budesonide Budesonide (Synonym: Budesonide Inhalation) | 1件: D00246
D00246
(Name: BUDESONIDE INHALATION) | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 |